Category: Head and Neck Cancer Group

EORTC Head and Neck Group: Young Investigator’s Program

9 Jan
Biostatistics

First european biomarker driven umbrella trial in recurrent / metastatic squamous cell carcinoma of the head & neck

26 Jun
Lisa-Licitra

Debiopharm and EORTC announce a collaboration to investigate Triptorelin for treatment of Salivary Gland Cancers

13 Jan
water-web

EORTC trial evaluates androgen deprivation therapy for patients with recurrent / metastatic androgen receptor expressing salivary gland cancer

10 Feb
profile

EORTC initiates randomized phase III study with Azanta’s Nimoral®

18 Aug
profile

EORTC and DAHANCA launch trial for patients with locally advanced squamous cell carcinoma of the head and neck

4 Jun
thyroid

EORTC trial opens for patients with differentiated or medullary thyroid cancer progressing after first line therapy

20 May
thyroid

EORTC head & neck cancer trial shows assessing HRQOL is valuable to both patients and their doctors

20 Nov
labo

Addressing treatment resistance in patients with squamous cell carcinoma of head and neck with Pr. Machiels and Blanpain

13 Sep

Abstracts accepted for the 2011 ASCO Annual Meeting

28 Apr
1 2 3 … 37